We use cookies to help provide you with the best possible online experience. Learn more

Press releases

Annual General Meeting in RaySearch Laboratories AB (publ)

Among other matters, the following decisions were made at the Annual General Meeting in RaySearch Laboratories, held May 19, 2005. Johan Löf, Erik Hedlund, Carl Filip Bergendal, Claes-Göran Fridh and Hans Wigzell were re-elected as members of the Board. Thomas Pousette was re-elected as deputy member. The Annual General Meeting resolved that the fee to the Board members who do not receive salary from the company shall be paid in the amount of SEK 520,000 for the period until the next Annual General Meeting, to be distributed as determined by the Board. In accordance with the Board’s and President’s proposal, the Annual General Meeting resolved that the company’s earnings be carried forward and that no dividend be paid. The Board and President were discharged from liability for the 2004 fiscal year. For further information, contact: Johan Löf, President RaySearch Laboratories AB +46 (0)8-545 061 30 or +46 (0)70 – 683 79 35 johan.lof@raysearchlabs.com About RaySearch RaySearch develops and sells software for radiation therapy for cancer treatment. The products are specially developed to optimize radiation therapy and the purpose is to adapt the radiation dose to the contours of the tumor, which allows high doses to be delivered to the tumor while minimizing the dose to surrounding healthy tissue. RaySearch, a spin-off from Karolinska Institutet, was formed in 2000. RaySearch has sold its product, RayOptimizer, to more than 800 hospitals around the world through a licensing agreement with Philips, enabling tens of thousands of patients to receive improved radiation therapy. RaySearch was listed on the Stockholm Stock Exchange O-list in November 2003. Sales of the products RayBiology and RayMachine began in 2004 and the partnership with Philips continues. RaySearch signed a licensing agreement with Nucletron in January 2004. The latter agreement made RaySearch's products available to a large number of new clinics worldwide and, consequently, increased the number of potential end-customers sharply. Delivery to clinics of the first products based on the partnership with Nucletron, OM-Optimizer, began in April 2005. RaySearch is based in Stockholm and currently has 26 employees. Company’s website: www.raysearchlabs.com